GlassScriptPhysician profile
Veronica L Schimp
NPI 1780621490
$4,607.22
in general payments reported to CMS, 2019-2025
20 companies · $13.46 in 2025
The $13.46 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,355 · 2020: $387 · 2021: $347 · 2022: $253 · 2023: $127 · 2024: $124 · 2025: $13.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,558.00 | 2019-2022 | |
| Clovis Oncology, INC. | $214.23 | 2019-2022 | |
| Applied Medical Resources Corporation | $143.10 | 2020 | |
| Abbvie INC. | $123.64 | 2024 | |
| Glaxosmithkline, LLC. | $98.30 | 2020-2025 | Zejula, Jemperli |
| Gauss Surgical INC. | $97.91 | 2019 | |
| Seagen INC. | $61.60 | 2022-2023 | Tivdak |
| Eisai INC. | $55.79 | 2019-2021 | |
| Asd Specialty Healthcare, LLC | $49.79 | 2019 | |
| Merck Sharp & Dohme LLC | $30.93 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $25.86 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.70 | 2023 | |
| Myriad Genetic Laboratories, INC. | $21.77 | 2023 | Precisetumor |
| Integra Lifesciences Corporation | $20.85 | 2019 | |
| Genentech USA, INC. | $20.45 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20.12 | 2019 | |
| Amgen INC. | $14.58 | 2019 | |
| Medtronic, INC. | $14.16 | 2021 | |
| Ethicon US, LLC | $13.44 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Schimp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.